Recruiting

L Max for Lung Health in Healthy Adult Athletes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

L Max

+ Placebo

Other
Who is being recruted

From 18 to 60 Years
+28 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Placebo-Controlled
Interventional
Study Start: January 2026
See protocol details

Summary

Principal SponsorClimatic, Inc.
Last updated: January 29, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 19, 2026

Actual date on which the first participant was enrolled.

This study is designed to understand if L Max, a new treatment, can effectively clean the lungs of healthy adult athletes. By assessing changes in lung health and athletic performance, researchers aim to see if L Max can improve these outcomes compared to a placebo, which is a non-active look-alike substance. This study is important as it may offer a way to enhance lung function and athletic capability, which could be beneficial in sports and physical activities. Participants in the study are required to wear an Oura Ring to track their activity and health continuously. They will conduct daily spirometry tests to measure lung health and fill out daily exercise and health logs. During the study, they will also complete three athletic performance tests, Participant Reported Outcome Surveys, and study product surveys. An optional exit survey is available at the end. These activities help researchers evaluate the effects of L Max accurately, ensuring a thorough understanding of its potential benefits and any possible risks.

Official TitleA RANDOMIZED PLACEBO CONTROLLED TRIAL OF L MAX IN HEALTHY ADULT ATHLETES
NCT07102680
Principal SponsorClimatic, Inc.
Last updated: January 29, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

120 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 60 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

16 inclusion criteria required to participate
Able to receive shipment of the product at an address within the United States
Able to use Oura, spirometry, and training apps
If diagnosed with exercise induce asthma, able to use inhaler only as rescue and not preventatively.
Tracks power and time during training
Show More Criteria
12 exclusion criteria prevent from participating
Pregnant, planning to become pregnant during the study, or lactating
History of COPD, long COVID, fibromyalgia, chronic fatigue syndrome, Lyme disease, or major cardiac or respiratory conditions
Have a significant illness, disease, or condition which, in the opinion of the principal investigator, may impact their ability to participate in the study or impact the study outcomes.
Daily/preventative inhaler use
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
Participants will complete up to a ten week study consisting of screening period, pre-study preparation period, baseline period, a 4-week product use period. Screening assessments, baseline questions, participant reported outcome surveys, exercise, health, and dosing logs, and adverse event reporting will be collected. Participants will have the option of participating in an end of study interview. This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study. Participants will receive the study product during the pre-study preparation period. Demographic and limited medical history data will be collected for the study.

Group II

Placebo
Participants will complete up to a ten week study consisting of screening period, pre-study preparation period, baseline period, a 4-week product use period. Screening assessments, baseline questions, participant reported outcome surveys, exercise, health, and dosing logs, and adverse event reporting will be collected. Participants will have the option of participating in an end of study interview. This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study. Participants will receive the study product during the pre-study preparation period. Demographic and limited medical history data will be collected for the study.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

People Science, Inc.

Los Angeles, United StatesOpen People Science, Inc. in Google Maps
Recruiting
One Study Center
L Max for Lung Health in Healthy Adult Athletes | PatLynk